Lisata Therapeutics Stock Analysis
| LSTA Stock | USD 2.65 0.01 0.38% |
Lisata Therapeutics is overvalued with Real Value of 2.17 and Hype Value of 2.65. The main objective of Lisata Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what Lisata Therapeutics is worth, separate from its market price. There are two main types of Lisata Therapeutics' stock analysis: fundamental analysis and technical analysis.
The Lisata Therapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Lisata Therapeutics' ongoing operational relationships across important fundamental and technical indicators.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lisata Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. Lisata Stock Analysis Notes
About 20.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.9. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Lisata Therapeutics recorded a loss per share of 2.3. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 15th of September 2022. Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease andor promote the regeneration of damaged tissue. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey. Lisata Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 27 people. To find out more about Lisata Therapeutics contact BSc B at 908 842 0100 or learn more at https://www.lisata.com.Lisata Therapeutics Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Lisata Therapeutics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Lisata Therapeutics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Lisata Therapeutics had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 1000 K. Net Loss for the year was (19.98 M) with profit before overhead, payroll, taxes, and interest of 1000 K. | |
| Lisata Therapeutics currently holds about 72.99 M in cash with (19.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 18.07, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 20.0% of the company outstanding shares are owned by corporate insiders |
Lisata Therapeutics Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Lisata Therapeutics previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Lisata Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 22.7 M.Technical Drivers
As of the 23rd of July, Lisata Therapeutics secures the Mean Deviation of 3.67, risk adjusted performance of 0.0533, and Downside Deviation of 4.52. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Lisata Therapeutics, as well as the relationship between them.Lisata Therapeutics Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Lisata Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Lisata Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Lisata Therapeutics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Lisata Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Lisata Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Lisata Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Tariq Imam over three months ago Insider Trading | ||
James Nisco over a year ago Disposition of 4000 shares by James Nisco of Lisata Therapeutics at 3.08 subject to Rule 16b-3 | ||
James Nisco over a year ago Disposition of 3000 shares by James Nisco of Lisata Therapeutics at 3.0 subject to Rule 16b-3 | ||
James Nisco over a year ago Disposition of 4000 shares by James Nisco of Lisata Therapeutics at 3.08 subject to Rule 16b-3 | ||
Buck Kristen K over a year ago Disposition of 50103 shares by Buck Kristen K of Lisata Therapeutics at 1.28 subject to Rule 16b-3 | ||
Wei Eric 1 over a year ago Lisata Therapeutics exotic insider transaction detected |
Lisata Therapeutics Outstanding Bonds
Lisata Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Lisata Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Lisata bonds can be classified according to their maturity, which is the date when Lisata Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| CABKSM 6208 18 JAN 29 Corp BondUS12803RAA23 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Lisata Therapeutics Predictive Daily Indicators
Lisata Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Lisata Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Lisata Therapeutics Forecast Models
Lisata Therapeutics' time-series forecasting models are one of many Lisata Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Lisata Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Lisata Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Lisata Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Lisata shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Lisata Therapeutics. By using and applying Lisata Stock analysis, traders can create a robust methodology for identifying Lisata entry and exit points for their positions.
Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease andor promote the regeneration of damaged tissue. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey. Lisata Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 27 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Lisata Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
| All Next | Launch Module |
Complementary Tools for Lisata Stock analysis
When running Lisata Therapeutics' price analysis, check to measure Lisata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lisata Therapeutics is operating at the current time. Most of Lisata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Lisata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lisata Therapeutics' price. Additionally, you may evaluate how the addition of Lisata Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |